TWO · 6696.TWO
Lin BioScience, Inc.
NT$159.00-NT$2.50 (-1.55%)
Lin BioScience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.19% below the high.
Loading market information…
TAI · 6550.TW · TWD
Stock price, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Polaris Group’s quoted price sits in the lower half of its reported 52-week range, 78.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Polaris Group’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$159.00-NT$2.50 (-1.55%)
Lin BioScience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.19% below the high.
NT$66.60+NT$1.20 (+1.83%)
Caliway Biopharmaceuticals Co. L’s quoted price sits in the lower half of its reported 52-week range, 64.57% below the high.
NT$39.05-NT$1.75 (-4.29%)
Pell Bio-Med Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 97.38% below the high.
NT$419.00-NT$3.50 (-0.83%)
Pegavision Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.12% below the high.
NT$45.80-NT$1.20 (-2.55%)
Oneness Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.29% below the high.
NT$28.55-NT$0.80 (-2.73%)
Center Laboratories, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.69% below the high.
NT$387.00-NT$13.00 (-3.25%)
Sunmax Biotechnology Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.97% below the high.
NT$57.40-NT$2.60 (-4.33%)
TaiMed Biologics Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.87% below the high.
